Chief medical officers (CMO) and chief information officers (CIO) believe that the medical industry in on the cusp of transformative change and this partnership will be a key driver of innovation. This collaboration will usher in an era of technological advances in healthcare, which we refer to as Future Care.
The deal follows by weeks Thermo Fisher's acquisition, for $1.7 billion, of gene therapy contract manufacturing organization Brammer Bio.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Brammer specializes in contract services for viral vector-based gene therapies. Panelists at a conference last week stressed the importance of manufacturing for gene therapy investors.
The investment banking company has tapped Dr. David Stark, who was previously at Mount Sinai, to serve as its CMO and head of HR data and analytics, reports Business Insider.
"[Being] the CEO of a publicly traded company is far more stressful than doing cardiac surgery," Qualcomm Life CMO Dr. James Mault said during a Tales from the Trenches event at Matter on March 28.
In a recent phone interview, Humana CMO Dr. Roy Beveridge chatted about value-based care, social determinants of health, 2018 predictions and what the Louisville, Kentucky-based payer has been up to.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Although the future of the healthcare world is unknown, a recent survey highlights the primary goals of healthcare leaders moving forward.
With the $1.7 billion acquisition of CRO and manufacturing company Lake Region Medical, Texas-based CRO Greatbatch has become one of the largest medtech-focused CROs in the world.